Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2005
10/06/2005US20050222141 N-(2,6-dichlorobenzoyl)-4-[1-methyl-7-(pyrrolidine-1-ylmethyl)-2,4-quinazoline-dione-3-yl]-L-phenylalanine trifluoroacetate; 4 integrin antagonist; antiinflammatory, anticarcinogenic agent, antiallergent; asthma, psoriasis, cardiovascular diseases, arterial sclerosis, restenosis, tumor proliferation
10/06/2005US20050222140 Improved DP-IV inhibitors increase the steady state concentrations of GLP-1 and GIP, resulting in improved glucose tolerance
10/06/2005US20050222134 Crystalline forms of 5, 11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepin-6-one
10/06/2005US20050220784 Quinazoline derivatives as medicaments
10/06/2005DE20122435U1 Mikronisiertes Zolpidem-Hemitartrat Micronized zolpidem hemitartrate
10/06/2005DE102004014304A1 Substituierte 1,4,8- Triazaspiro[4,5]decan-2-on-Verbindungen Substituted 1,4,8- triazaspiro [4,5] decan-2-one compounds
10/06/2005DE102004014296A1 Substituierte 1,4,8-Triazaspiro[4.5]decan-2-on-Verbindingen Substituted 1,4,8-triazaspiro [4.5] decan-2-one Verbindingen
10/06/2005CA2563164A1 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
10/06/2005CA2561488A1 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonists
10/06/2005CA2560896A1 Imidazole compounds
10/06/2005CA2560857A1 Tetrahydro-.beta.-carboline compounds and use thereof
10/06/2005CA2560700A1 Tetrahydrocarbazoles and derivatives
10/06/2005CA2559733A1 Inhibitors of histone deacetylase
10/05/2005EP1582520A1 Novel parp inhibitors
10/05/2005EP1582516A1 Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same
10/05/2005EP1581539A2 Novel tyrosine kinase inhibitors
10/05/2005EP1581533A2 Novel benzonaphthyridines
10/05/2005EP1581532A1 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
10/05/2005EP1581531A1 Pyridino[2,3-d]pyrimidine derivatives as selectiive kdr and fgfr inhibitors
10/05/2005EP1581530A1 Indane compounds as ccr5 antagonists
10/05/2005EP1581521A1 Fused heterocyclic derivatives as ppar modulators
10/05/2005EP1581491A1 Indole derivatives as ppar modulators
10/05/2005EP1581309A2 Kinase modulators
10/05/2005EP1581221A2 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
10/05/2005EP1581220A2 2-nh-heteroarylimidazoles with antibacterial activity
10/05/2005CN1678615A Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists
10/05/2005CN1678612A Viral inhibitors
10/05/2005CN1678591A New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
10/05/2005CN1678581A Indolin phenylsulfonamide derivatives
10/05/2005CN1678372A Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/05/2005CN1678352A Adhesive patch
10/05/2005CN1678315A Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
10/05/2005CN1678303A Keto cannabinoids with therapeutic indications
10/05/2005CN1221554C Pyrano [2, 3-C] imidazo[-1, 2-A] pyridine derivatives and mecicine composition for treatment of traitement gastrointestinal disorders
10/05/2005CN1221553C Tricyclic imidazopyridines and medicine composition thereof
10/05/2005CN1221552C N-([1, 2, 4] triazoloazinyl) thiophene sulfonamide compounds as herbicides
10/05/2005CN1221551C Aminotriazolopyridine derivatives as adenosine receptor ligands
10/05/2005CN1221533C 7-amino-1H-indole derivatives
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/04/2005US6951943 Integrin inhibitors
10/04/2005US6951938 Aryl fused azapolycyclic compounds
10/04/2005US6951874 Compounds
10/04/2005US6951871 Indole derivatives useful as histamine H3 antagonists
10/04/2005US6951867 N-substituted piperidinyl-imidazopyridine compounds as 5-HT4 receptor modulators
10/04/2005US6951865 Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same
10/04/2005US6951863 Pyridoarylphenly oxazolidinone antibacterials, and related compositions and methods
10/04/2005US6951854 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
10/04/2005US6951851 Substituted pyrazoles
10/04/2005US6951850 Dipeptide derivatives
09/2005
09/29/2005WO2005090367A1 Prodrugs of piperazine and substituted piperidine antiviral agents
09/29/2005WO2005090353A1 PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS
09/29/2005WO2005090348A1 Pyrazolo ’3,4-b! pyridine compounds, and their use as phosphodiesterase type 4 (pde4) inhibitors
09/29/2005WO2005090347A1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors
09/29/2005WO2005090346A2 7, 8, 9, 10- tetrahydro-imidazo [2,1-a] isoquinoline derivatives and their use as gastric acid secretion inhibitors
09/29/2005WO2005090345A1 Novel n- (alkoxyalkyl) carbamoyl - substituted 6-phenyl-benzonaphthyridine derivatives and their use as pde3/4 inhibitors
09/29/2005WO2005090344A1 Novel dichloro-phenyl-pyrido [2,3-d] pyrimidine derivates, their manufacture and use as pharmaceutical agents
09/29/2005WO2005090343A1 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
09/29/2005WO2005090336A1 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands
09/29/2005WO2005090332A1 Substituted quinazoline or pyridopyrimidine derivative
09/29/2005WO2005090316A1 HYDANTOINS HAVING RNase MODULATORY ACTIVITY
09/29/2005WO2005090292A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005089764A1 Carboline derivatives useful in the inhibition of angiogenesis
09/29/2005WO2005089763A1 Imidazopyridine and imidazopyrimidine derivatives as antibacterial agents
09/29/2005WO2005089511A2 Novel pharmaceutical forms, and methods of making and using the same
09/29/2005WO2005089118A2 Novel bicyclic compounds as modulators of androgen receptor function and method
09/29/2005WO2005089094A2 Materials and methods for the preparation of anisotropically-ordered solids
09/29/2005WO2005073224A3 Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer
09/29/2005WO2005067900A3 Azabenzofuran substituted thioureas as inhibitors of viral replication
09/29/2005WO2005065183A3 Mitotic kinesin inhibitors
09/29/2005WO2005062991A3 Ten and 20-di-esterification derivatives of camptothecins and methods to treat cancers
09/29/2005WO2005054183A3 Quinolinone based protein kinase inhibitors
09/29/2005WO2005042697A3 Compounds, compositions and methods
09/29/2005WO2005025507A3 Dihydropyridine compounds for treating or preventing metabolic disorders
09/29/2005WO2005018567A3 Compounds and compositions for the treatment of diabetes and diabetes-related disorders
09/29/2005WO2005018556A3 Hydroxylamine substituted imidazo-containing compounds
09/29/2005WO2005009398A3 Tetracyclic benzamide derivatives and methods of use thereof
09/29/2005WO2004094418A8 Imidazopyridine compounds having 5-ht4 receptor agonistic activity and 5-ht3 receptor antagonistic activity
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215610 Such as 3-(4-(2-[2-(3,5-Difluoro-phenyl)-acetylamino]-pentanoylamino)-imidazol-1-yl)-butyric acid methyl ester; secretase, A beta -peptide inhibitor; neurogenerative and neurological diseases: Alzheimer's disease; Notch signaling pathway inhibitor; antiinflammatory agent, asthma, autoimmune diseases
09/29/2005US20050215582 Substituted pyrrolopyridines
09/29/2005US20050215581 Administering the compound N-{2-[2-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)ethoxy]ethyl}morpholine-4-carboxamide inducing cytokine biosynthesis; Viricides; anticancer agents; immunology moderators
09/29/2005US20050215580 Tetrahydrocarboline compounds as anticancer agents
09/29/2005US20050215577 Tetrahydrocarbazoles and derivatives
09/29/2005US20050215572 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
09/29/2005US20050215570 Process for the preparation of N-([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides
09/29/2005US20050215557 For therapy and prophylaxis of inflammatory diseases, asthma, atopic dermatitis, urticaria, allergic diseases, nephritis, nephropathy, hepatitis, arthritis or rheumatoid arthritis etc
09/29/2005US20050215555 Imidazo[1,5-a]pyridine serotonin (5-HT) 5-HT2A receptor antagonists such as 1-phenyl-3-[1-(2-phenylethyl)piperidin-4-yl]imidazo[1,5-a]pyridine; psychological disorders, sleep disorders, addiction, cardiovascular disorders, epilepsy, glaucoma
09/29/2005US20050215546 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carboxylic acid-{(R)-2-(4-amino-3,5-dibromo-phenyl)-1-[1-(3-dimethylamino-propyl)-1H-benzimidazol-2-yl]-ethyl}-amide; calcitonin gene related peptide antagonist; antiinflammatory agent, vasodilator, arthritis, asthma, diabetes type 2
09/29/2005US20050215541 Alzheimer's disease; benzodiazapines
09/29/2005CA2560286A1 Substituted quinazoline or pyridopyrimidine derivative
09/29/2005CA2560253A1 Prodrugs of piperazine and substituted piperidine antiviral agents
09/29/2005CA2560206A1 7, 8, 9, 10- tetrahydro-imidazo [2,1-a] isoquinoline derivatives and their use as gastric acid secretion inhibitors
09/29/2005CA2559408A1 Carboline derivatives useful in the inhibition of angiogenesis
09/29/2005CA2559229A1 Imidazopyridine and imidazopyrimidine derivatives as antibacterial agents
09/29/2005CA2559200A1 Novel n- (alkoxyalkyl) carbamoyl - substituted 6-phenyl-benzonaphthyridine derivatives and their use as pde3/4 inhibitors
09/29/2005CA2559196A1 Novel dichloro-phenyl-pyrido [2,3-d] pyrimidine derivates, their manufacture and use as pharmaceutical agents
09/29/2005CA2558023A1 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands
09/29/2005CA2557896A1 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
09/29/2005CA2554610A1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors
09/29/2005CA2554609A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
1 ... 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 ... 646